HIKAL - Hikal | Wealthrox

Hikal

HIKAL · Pharma > Pharmaceuticals & Drugs · Chairman: Jai Hiremath · MD: Jai Hiremath · Listing date: Feb. 15, 2001 · Employees: 1528 · Navi Mumbai · http://www.hikal.com

Stock Price vs Company Growth

1.7%

4.8%

3.0%

2.6%

6.5%

0.6%

12.0%

10y

16.4%

all

12.0%

🤔 How to analyze this graph?

Last Traded Price

₹ 297 1.7%

261

331

Company Overview

Sales

1,816 Cr

Growth: -4.7%

Profit after Tax

71.6 Cr

Growth: -12.5%

Small Cap

3,668 Cr

P/E: 51.2x

Industry P/E: 35.0x

Fundamentals

Sales (Cr)	₹ 1,816
Growth	-4.7%
EBITDA	14.4%
P/S	2.0x
Dividend	0.4%
P/E	51.2x
Book Value	₹ 94.8
PEG Ratio	-10.8x
ROE	6.2%
P/B	3.1x

Shareholding Pattern

Institutions

Government Pension Fund Global

2.31 %

Promoters

Kalyani Investment Company Limited

31.36 %

Shri Badrinath Investment Pvt Ltd

16.15 %

Shri Rameshwara Investment Pvt Ltd

7.96 %

Sugandha Jai Hiremath

7.84 %

Bf Investment Limited

2.65 %

Others

Si Investments And Broking Private Limited

1.62 %

Llp

0.4 %

Iepf

0.21 %

Increase Decrease No change

Company Profile Detailed

Established in 1988 Hikal is a reliable partner to companies in the Pharmaceuticals, Biotech, Agrochemicals and Specialty Chemicals industries. They provide world-class Active Ingredients, Intermediates and R&D services and solutions in a safe, secure and confidential manner. Their advanced infrastructure has been inspected and approved by globally recognized bodies such as the USFDA. Hikal is a company built on enduring relationships.

Belongs to (6 Indices) view more

Investors (60)

himalaya...

iepf

idfc.ste...

Followers (5)

mike2

nitin29

vishal48